Showing all 3 results
Citalopram Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed exclusively in secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the chemical stability of the hydrobromide salt.
Active Ingredient Strength Primary Clinical Function Citalopram Hydrobromide USP/Ph.Eur. 10 mg / 20 mg The Primary Care Anchor: The definitive starting and maintenance doses utilized for the vast majority of patients with moderate depression or panic disorder. Citalopram Hydrobromide USP/Ph.Eur. 40 mg The Severe Refractory Payload: The maximum therapeutic dose utilized for severe depression. (Note: Doses above 40mg are strictly avoided due to cardiac risks). Excipients Lactose Monohydrate / Maize Starch / Croscarmellose Sodium / Magnesium Stearate / Hypromellose / Titanium Dioxide (Film Coat) Diluent / Binder / Superdisintegrant / Lubricant / Opaque Coating (Engineered specifically utilizing High-Shear Wet Granulation to ensure 100% uniformity of the active API, providing a smooth, fast-acting dissolution profile that matches the originator brand). *Pack Sizes: 10×10 Blisters or 28-Tablet Calendar Packs (Optimized for monthly psychiatric compliance).
Desvenlafaxine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix Extended-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical and physical stability of the controlled-release polymer.
Active Ingredient Strength Primary Clinical Function Desvenlafaxine Succinate USP/Ph.Eur.
(Equivalent to Desvenlafaxine base)50 mg (ER) The Global Therapeutic Standard: The definitive, highly efficacious starting and maintenance dose utilized for the vast majority of patients suffering from Major Depressive Disorder. Desvenlafaxine Succinate USP/Ph.Eur. 100 mg (ER) The Severe Refractory Macrodose: High-efficacy therapeutic payload utilized strictly for severe, treatment-resistant depression where maximum norepinephrine reuptake inhibition is required. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Talc / Magnesium Stearate / Premium Polymeric Film Hydrophilic ER Matrix / Diluent / Glidant / Lubricant / Film-Coating (Engineered specifically utilizing high-viscosity Hypromellose. Upon contact with gastric fluid, the tablet forms a thick, gelatinous outer layer that slowly erodes over 24 hours, guaranteeing a smooth, flat pharmacokinetic curve to prevent violent nausea and serotonin spikes) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day psychiatric dispensing regimens).
Rasagiline Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated or Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly sensitive mesylate salt.
Active Ingredient Strength Primary Clinical Function Rasagiline Mesylate INN/Ph.Eur. 0.5 mg (Base Equivalent) Adjunct Standard: Initiating dose when used in combination with Levodopa. Rasagiline Mesylate INN/Ph.Eur. 1 mg (Base Equivalent) Global Clinical Standard: Maximum daily dose for monotherapy or advanced adjunct therapy. Excipients Mannitol / Maize Starch / Pregelatinized Starch / Colloidal Silicon Dioxide / Stearic Acid Diluent / Binder / Superdisintegrant / Glidant (Engineered for immediate gastric dissolution and rapid crossing of the blood-brain barrier) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict high-compliance 30-day chronic neurology dispensing regimens).
